During the College's Annual Scientific Meeting, Twitter was flooded with the latest allergy info from our sessions. Allergists who were not able to make it to Seattle could follow along from home, and attendees were able to help spread the latest and greatest evidence-based science around the world. Here at the College, we deeply appreciate our College members and meeting attendees who like and retweet our posts and contribute their own, so we've rounded up some of the best pearls tweeted during the meeting for you to enjoy.
Food allergy Atopic dermatitis Asthma Anaphylaxis Immunotherapy
On food allergy:
David Fleischer: Peanut OIT likely coming in 2019, however, are practices prepared for the increase in phone calls, treatment of reactions, policies and procedures and education of staff to provide this service? #ACAAI18
— Gerald Lee MD (@DrGerryLee) November 17, 2018
Oral food challenges are the gold standard 'test' to diagnose #foodallergy or determine if someone has developed tolerance. When conducted properly, they are safe and exceptionally helpful. Many factors can help determine a good candidate. #ACAAI18 pic.twitter.com/a8G1p2Ul1a
— Dr. Dave Stukus (@AllergyKidsDoc) November 17, 2018
All pecan allergic patients are allergic to walnut! All pistachio allergic patients are allergic to cashews. The opposite is not always true (66% for both). Oral food challenges remain gold standard for diagnosis. #ACAAI18
— Elias Akl MD (@asthmallergydoc) November 16, 2018
important point regarding PN and other foods ‘off the shelf’ for OIT—there can be significant (and large) variability of different allergens/proteins in different products dosed by the same weight! from Dr Wood’s pro-con debate #ACAAI18 pic.twitter.com/IUJtlVQntS
— Karen Robbins, MD (@karenrobbinsmd) November 17, 2018
On atopic dermatitis:
Illuminating session: Jonathan Silverberg of Northwestern Dermatology on Biologics in Atopic Dermatitis, chronic urticaria, psoriatic diseases, hidradenitis. Chronic Cutaneous lesions heal slowly though itch may improve first. Keep topical steroid on board too. #ACAAI18 pic.twitter.com/91YWchSqo6
— Atoosa Kourosh (@AllergyHealth) November 15, 2018
Atopic dermatitis: IgE reactivation to bacterial antigens is more frequent in patients with HDM vs non HDM sensitization #ACAAI18
— WAOJM (@WAOJM) November 16, 2018
TH2A cells: the future of atopic markers including CRTH2, CD161, and CD49d, with low expression of CD45RB and CD27 #ACAAI18
— Dr Alexei Gonzalez (@alexeigonzmd) November 16, 2018
On asthma
Busse: biomarkers like feno and eosinophils can help guide which biologics may be most effective in severe asthma. #ACAAI18
— Dr. Sydney Leibel (@saleibel) November 18, 2018
Specific environmental allergen immunotherapy reduces development of asthma in children. #ACAAI18 children with atopic disease need ABAI certified allergists @AmAcadPeds pic.twitter.com/qVI9I3wysf
— Andrew D. Collins, MD (@AndrewLSUmd) November 18, 2018
#ACAAI18 "Rules of Two" Generally, a patient should be on a daily controller medication if he or she: have asthma symptoms/attacks more than twice a week. wakes up due to asthma symptoms more than twice a month.
— Dr. Ellis (@DrAnneEllis) November 18, 2018
Dr Bukstein practices A/I in inner city Milwaukee: “Asthma is a disease of poor communication rather than increased inflammation.” Feels like I’m listening to a pre-game talk from the Vince Lombardi of allergy #ACAAI18
— Kevin Parks MD (@kparksmd) November 18, 2018
On anaphylaxis:
The majority of patients seeking OIT are mostly interested in decreasing risk of anaphylaxis; < 10% report wanting to fully incorporate the food into their diet. #ACAAI18
— Melinda Rathkopf, MD (@mrathkopf) November 18, 2018
#ACAAI18 Mawhirt's study involved 45 medical students and internal medicine residents. Median time from start of case to diagnosis of anaphylaxis was 6 min, only 3 groups administered the epi autoinjector proprerly
— Dr. Ellis (@DrAnneEllis) November 18, 2018
‘Tweens with #FoodAllergy in Australia had higher risk of recent anaphylaxis if female, allergic to nuts, have asthma or have multiple allergies. Should we be surprised that 85% of reactions were not treated even if anaphylactic? #ACAAI18 pic.twitter.com/9A92UAGBuH
— Atoosa Kourosh (@AllergyHealth) November 16, 2018
As being discussed right now by Dr. Julie Wang, a good first step for uniform anaphylaxis management would be for even health care providers to come up with a more objective definition of what is anaphylaxis and what requires epinephrine use. #ACAAI18
— Joao Pedro Lopes, MD (@JPLopesMD) November 16, 2018
On immunotherapy:
Dr Woods explains AR101 for OIT peanut allergy, new data just published in NEJM. #ACAAI18 67% of pts tolerated over 600mg only 2.2% w serious AE.
— Dr Stan Fineman (@DrStanFineman) November 18, 2018
We have a wealth of data sitting on our EMR- just need the time to analyze – including the high number of kids who come to us for OIT that aren't actually allergic – an Oral challenge can help us to not even need to perform OIT #ACAAI18
— Douglas Mack (@DrDougMackMD) November 18, 2018
EPIT therapy more effective than placebo in desensitizing peanut allergic pts favorably suggests reduced risk of reaction to accidental peanut ingestion in certain product categories such as ice cream and more. #foodallergy #ACAAI18 pic.twitter.com/e8B5SdwMMb
— Priya Bansal, MD (@Allergygal1) November 18, 2018
Multiple allergen sublingual immunotherapy (SLIT) seems to be safe but some potential loss of efficacy with more than 2 allergens. Plus, compliance is always another potential issue with SLIT. #ACAAI18
— Joao Pedro Lopes, MD (@JPLopesMD) November 16, 2018
